Development of novel avenues to overcome challenges facing CAR T cells
Author:
Publisher
Elsevier BV
Subject
Biochemistry (medical),Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)
Reference115 articles.
1. Chimeric antigen receptor T cell therapy: 25years in the making;Gill;Blood Rev,2015
2. Cancer-associated fibroblasts and tumor growth–bystanders turning into key players;Ostman;Curr Opin Genet Dev,2009
3. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity;Wang;Cancer Immunol Res,2014
4. Dual-specific chimeric antigen receptor T cells and an indirect vaccine eradicate a variety of large solid tumors in an immunocompetent, self-antigen setting;Slaney;Clin Cancer Res,2017
5. TanCAR: a novel bispecific chimeric antigen receptor for cancer immunotherapy;Grada;Mol Ther Nucleic Acids,2013
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Radioimaging of Activated T Cells in Preclinical and Clinical Cancer Investigations;Nuclear Medicine and Immunology;2021-11-25
2. Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma;Biomedicine & Pharmacotherapy;2020-03
3. Imaging activated T cells predicts response to cancer vaccines;Journal of Clinical Investigation;2018-05-14
4. Precision Medicine in Pediatric Neurooncology: A Review;ACS Chemical Neuroscience;2017-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3